v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (13,967) $ (21,761)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, amortization, and impairments 2,360 2,584
Non-cash interest expense 346 299
Write-down of inventories 52 (81)
Stock-based compensation expense 6,284 5,524
Change in fair value of warrant liabilities (826) 207
Other 56 244
Changes in operating assets and liabilities:    
Accounts receivable 857 (751)
Inventories 1,423 (1,391)
Prepaid expenses and other assets (570) (376)
Vendor advances 29 (1,057)
Accounts payable (1,970) 703
Deferred revenue (470) (1,338)
Change in operating lease assets and liabilities (201) (163)
Accrued expenses and other liabilities (5,080) (3,310)
Net cash used in operating activities (11,677) (20,667)
Cash flows from investing activities:    
Purchases of property, equipment, and intangible assets, including capitalized software (353) (1,138)
Net cash used in investing activities (353) (1,138)
Cash flows from financing activities:    
Proceeds from exercise of stock options and warrants 133 0
Net proceeds from share offering 81,109 0
Payments to tax authorities for restricted stock units withheld (2,775) 0
Net cash provided by financing activities 78,467 0
Net increase (decrease) in cash, cash equivalents, and restricted cash 66,437 (21,805)
Cash, cash equivalents, and restricted cash, beginning of period 92,790 138,650
Cash, cash equivalents, and restricted cash, end of period $ 159,227 $ 116,845